Russian CTEPH registry aims to uncover key prognostic factors
NCT ID NCT07254078
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is collecting information from 500 people with chronic thromboembolic pulmonary hypertension (CTEPH) in Russia. Researchers want to learn which factors most affect long-term survival and health. Participants will have their medical history, symptoms, and test results recorded over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Medical Research Center of Cardiology after academician E.I. Chazov
RECRUITINGMoscow, Russia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Prepping the body before heart surgery: could exercise shorten hospital stays?
- Registry aims to uncover long-term outlook for rare blood-clot lung disease
- Could pedaling backward help heart and lung patients get stronger?
- Recovery after lung surgery: new study tracks Patients' strength and breathing
- Kidney risk after lung surgery: new clues from 150 patients
- New Radiation-Free lung scanner could transform monitoring of blood clot surgery